Cargando…

IMPARTER, Phase 1 of an intervention to improve patients’ understanding of gene expression profiling tests in breast cancer

PURPOSE: To compare participants’ knowledge about gene expression profiling (GEP) tests and recurrence risks after reading an information leaflet with that following viewing of an information film. METHODS: Using a randomised cross-over design, at time-point one (T1), women aged 45–75 years without...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fallowfield, L. J., Farewell, D., Jones, H., May, S., Catt, S., Starkings, R., Jenkins, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750374/ https://www.ncbi.nlm.nih.gov/pubmed/34982321 http://dx.doi.org/10.1007/s10549-021-06491-2

Ejemplares similares

Talking about risk in the context of genomic tests (TARGET): development and evaluation of an educational program for clinicians
por: Fallowfield, L., et al.
Publicado: (2019)

A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer
por: Starkings, Rachel, et al.
Publicado: (2020)

Patient-reported outcome measures of the impact of cancer on patients’ everyday lives: a systematic review
por: Catt, Susan, et al.
Publicado: (2016)

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer
por: Moreno-Aspitia, Alvaro, et al.
Publicado: (2013)

Promoter hypermethylation profiling of distant breast cancer metastases
por: Schrijver, Willemijne A. M. E., et al.
Publicado: (2015)

Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer
por: Tahiri, Andliena, et al.
Publicado: (2020)

Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer
por: Zhang, Hua, et al.
Publicado: (2015)

Improving breast cancer services for African-American women living in St. Louis
por: Noel, Lailea, et al.
Publicado: (2015)

Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile
por: Suelmann, B. B. M., et al.
Publicado: (2021)

Improved pharmacokinetic and pharmacodynamic profile of a novel PEGylated native Erwinia chrysanthemi L-Asparaginase
por: Modi, Tapasvi, et al.
Publicado: (2021)

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
por: Dekker, T. J. A., et al.
Publicado: (2015)

Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy
por: Li, Kai, et al.
Publicado: (2020)

Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention
por: Walter, Katherine R., et al.
Publicado: (2018)

Do drugs offering only PFS maintain quality of life sufficiently from a patient’s perspective? Results from AVALPROFS (Assessing the ‘VALue’ to patients of PROgression Free Survival) study
por: Jenkins, V., et al.
Publicado: (2018)

Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survival
por: Giannoudis, Athina, et al.
Publicado: (2021)

The informational roles and psychological health of members of 10 oncology multidisciplinary teams in the UK
por: Catt, S, et al.
Publicado: (2005)

Breast cancer research and treatment reconstruction of unilateral breast structure using three-dimensional ultrasound imaging to assess breast neoplasm
por: Lu, Yuanyuan, et al.
Publicado: (2019)

Clinicians’ attitudes towards clinical trials of cancer therapy
por: Ford, E, et al.
Publicado: (2011)

Association of reproductive history with breast tissue characteristics and receptor status in the normal breast
por: Gabrielson, Marike, et al.
Publicado: (2018)

SEARCHBreast: a new resource to locate and share surplus archival material from breast cancer animal models to help address the 3Rs
por: Blyth, Karen, et al.
Publicado: (2016)

Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients
por: Mast, Mirjam E., et al.
Publicado: (2014)

Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)
por: Perez, Edith A., et al.
Publicado: (2013)

Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
por: Jinna, Nikita D., et al.
Publicado: (2023)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients
por: Lattimore, Vanessa, et al.
Publicado: (2020)

The molecular diversity of Luminal A breast tumors
por: Ciriello, Giovanni, et al.
Publicado: (2013)

Clever-1 positive macrophages in breast cancer
por: Mutka, Minna, et al.
Publicado: (2022)

PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022)

Intrinsic subtypes in Ethiopian breast cancer patient
por: Desalegn, Zelalem, et al.
Publicado: (2022)

Contrast enhanced mammography in breast cancer surveillance
por: Elder, Kenneth, et al.
Publicado: (2023)

Tumor microenvironment and breast cancer survival: combined effects of breast fat, M2 macrophages and hyaluronan create a dismal prognosis
por: Tiainen, Satu, et al.
Publicado: (2019)

Recurrent read-through fusion transcripts in breast cancer
por: Varley, Katherine E., et al.
Publicado: (2014)

Inflammatory breast cancer (IBC): clues for targeted therapies
por: Fernandez, Sandra V., et al.
Publicado: (2013)

Retrospective analysis of metastatic behaviour of breast cancer subtypes
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2015)

Phenotypic characterisation of breast cancer: the role of CDC42
por: Chrysanthou, Eleni, et al.
Publicado: (2017)

The spectrum of ATM missense variants and their contribution to contralateral breast cancer
por: Broeks, Annegien, et al.
Publicado: (2007)

Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer
por: Nitze, Louise Maymann, et al.
Publicado: (2013)

Engineering targeted chromosomal amplifications in human breast epithelial cells
por: Springer, Simeon, et al.
Publicado: (2015)

Inherited predisposition to breast cancer among African American women
por: Churpek, Jane E., et al.
Publicado: (2014)

High tumor budding stratifies breast cancer with metastatic properties
por: Salhia, Bodour, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ndnvf3bhtmmm4j69ab45423ger